DMC Best Practices: What Biotechs and Sponsors Should Know  

1 minute read

Published: August 5th, 2025

Data Monitoring Committees (DMC) are a critical part of the clinical trial process, independently assessing the safety of an investigational product and at times the futility/efficacy. Successfully navigating DMC set-up, logistics, and independent data review can be complex, especially for biotech and smaller sponsors without in-house expertise. 

Speakers:
  • Lucy Clark, Statistics Manager
  • Lisa Gibbons, Senior Statistician
  • Matt George (Moderator), Senior Statistician
Learning Points :
  • Share best practices for establishing and running an effective Data Monitoring Committee
  • Explore the critical role of an Independent Data Analysis Centre (IDAC) in ensuring compliant, high-quality DMC operations.
  • Present real-world case studies showcasing successful DMC implementation in high-stakes clinical trials.
Complete the form below to access the recording and slides:

Related articles

Bridging the Efficacy Effectiveness Gap in Rare Diseases with RWD

Bridging the Efficacy Effectiveness Gap in Rare Diseases with RWD

June 2nd, 2026 1 minute read

About This Webinar Drug development in rare diseases requires the most efficient use of limited data, across both cli...

Driving Clinical Research with AI: From Early Discovery to Regulatory-Grade Insights

Driving Clinical Research with AI: From Early Discovery to Regulatory-Grade Insights

May 19th, 2026 1 minute read

Join us for a transformative three-part webinar series, “Driving Clinical Research with AI,” where indust...

Causal Inference Through a Regulatory Lens

Causal Inference Through a Regulatory Lens

May 15th, 2026 1 minute read

About This Webinar As expectations for robust, real-world evidence continue to grow, understanding how regulators eva...